Cargando…
Restriction of Influenza A Virus by SERINC5
Serine incorporator 5 (Ser5), a transmembrane protein, has recently been identified as a host antiviral factor against human immunodeficiency virus (HIV)-1 and gammaretroviruses like murine leukemia viruses (MLVs). It is counteracted by HIV-1 Nef and MLV glycogag. We have investigated whether it has...
Autores principales: | Lai, Kin Kui, Munro, James B., Shi, Guoli, Majdoul, Saliha, Compton, Alex A., Rein, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765469/ https://www.ncbi.nlm.nih.gov/pubmed/36409124 http://dx.doi.org/10.1128/mbio.02923-22 |
Ejemplares similares
-
SERINC5 restricts influenza virus infectivity
por: Zhao, Fei, et al.
Publicado: (2022) -
Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry
por: Leonhardt, Susan A., et al.
Publicado: (2023) -
IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag
por: Ahi, Yadvinder S., et al.
Publicado: (2020) -
SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef
por: Usami, Yoshiko, et al.
Publicado: (2015) -
Lessons in self-defence: inhibition of virus entry by intrinsic immunity
por: Majdoul, Saliha, et al.
Publicado: (2021)